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Interferon regulatory factor 8 (IRF8), a myeloid lineage transcription factor,
emerges as an essential regulator for microglial activation. However, the precise role of
IRF8 during Japanese encephalitis virus (JEV) infection in the brain remains elusive. Here,
we report that JEV infection enhances IRF8 expression in the infected mouse brain.
Comparative transcriptional proﬁling of whole-brain RNA analysis and validation by quantitative reverse transcription-PCR (qRT-PCR) reveals an impaired interferon gamma (IFN-g)
and related gene expression in Irf8 knockout (Irf82/2)-infected mice. Further, Ifng knockout
(Ifng2/2) mice exhibit a reduced level of Irf8. Both Ifng2/2 and Irf82/2 mice exhibit signiﬁcantly reduced levels of activated (CD11b1 CD45hi, CD11b1 CD45lo, Cd68, and CD86) and
inﬁltrating immune cells (Ly6C1, CD4, and CD8) in the infected brain compared to those
of wild-type (WT) mice. However, a higher level of granulocyte cell (Ly6G1) inﬁltration is
evident in Irf82/2 mice as well as the increased concentration of tumor necrosis factor
alpha (TNF-a), interleukin-6 (IL-6), monocyte chemoattractant protein 1 (MCP1) levels in
the brain. Interestingly, neither the Irf82/2 nor the Ifng2/2 conferred protection against lethal JEV challenge to mice and exhibit augmentation in JEV replication in the brain. The
gain of function of Irf8 by overexpressing functional IRF8 in an IRF8-deﬁcient cell line
attenuates viral replication and enhances IFN-g production. Overall, we summarize that in
the murine model of JEV encephalitis, IRF8 modulation affects JEV replication. We also
show that lack of Irf8 affects immune cell abundance in circulation and the infected brain,
leading to a reduction in IFN-g level and increased viral load in the brain.
IMPORTANCE Microglial cells, the resident macrophages in the brain, play a vital role in
Japanese encephalitis virus (JEV) pathogenesis. The deregulated activity of microglia can
be lethal for the brain. Therefore, it is crucial to understand the regulators that drive
microglia phenotype changes and induce inﬂammation in the brain. Interferon regulatory
factor 8 (IRF8) is a myeloid lineage transcription factor involved in microglial activation.
However, the impact of IRF8 modulation on JEV replication remains elusive. Moreover,
the pathways regulated by IRF8 to initiate and amplify pathological neuroinﬂammation
are not well understood. Here, we demonstrated the effect of IRF8 modulation on JEV
replication, microglial activation, and immune cells inﬁltration in the brain.
KEYWORDS IRF8, microglial activation, IFN-g, neuroinﬂammation, Japanese

encephalitis virus, interferons, microglia
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apanese encephalitis virus (JEV) is a neurotropic virus and the leading cause of viral
encephalitis in Asia. About 70,000 cases are reported each year, of which approximately 20% to 30% are fatal (1). The patients who recover from infection develop
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severe neurological and psychiatric sequelae. Microglial cells, the resident macrophages in the brain, play a vital role in JEV pathogenesis. Microglia become activated
in response to JEV infection, enhancing the prolonged release of proinﬂammatory
mediators in the brain (reviewed in reference 2). It is now evident that microglia can
have both neuroprotective and neurotoxic effects. The deregulated activity of microglia can be lethal for the brain. Several reports indicated that activated microglia may
damage or induce the apoptotic death of neurons, directly releasing toxic mediators
such as cytokines and free radicals or indirectly attracting activated T cells, monocytes,
and neutrophils into the central nervous system (CNS) (3). Therefore, it is critical to
understand the mediators that drive changes in microglia phenotypes during JEV
infection.
Recently, interferon regulatory factor 8 (IRF8), a myeloid lineage transcription factor,
was identiﬁed as a critical molecule for microglial activation (4). IRF8 was also extensively studied for its functional signiﬁcance in innate and adaptive immune response
(5, 6). IRF8 is a transcription factor expressed in immune cells, such as lymphocytes,
dendritic cells, macrophages, and microglial cells. IRF8 may activate a set of gene
expressions that transforms microglia into a reactive phenotype (7). Overexpression of
IRF8 in microglial cells helps microglia reach a proinﬂammatory-reactive state.
Simultaneously, deﬁciency of IRF8 in mice conferred them resistance to peripheral
nerve injury (4) and experimental cerebral malaria (8). IRFs have a highly conserved
DNA binding domain (120 amino acids). The N termini of the domain recognize the
interferon (IFN)-stimulated response element (ISRE) DNA motif. In contrast, the variable
IRF association domain (IAD) determines the binding afﬁnity to other protein partner
molecules acting as a regulatory domain (9).
Previous studies have revealed the role of IRFs in the development, differentiation,
and function of the immune cell (9). Irf8R294C mutant mice showed monocyte polarization
to granulocyte lineage (neutrophils) with chronic myeloid leukemia (CML) syndrome in
BXH2 mice. BXH2 mice are also susceptible to vesicular stomatitis virus (VSV) infection
and generate an inadequate antiviral response in Irf8 mutant mice (10). Horiuchi et al.
reported that IRF8-deﬁcient microglia are not phenotypically and functionally equivalent
to wild-type microglia, as they were less capable of sensing tissue damage due to their
less extended processes (11). So, IRF8 regulates the morphology of microglia during homeostasis and inﬂammatory condition. A subsequent study by Berghout et al. demonstrated severe loss of IRF8 function in BXH2 mice that completely protects the animals
against cerebral malaria, preventing neurological symptoms with prolonged postinfection
survival of BXH2 mice (8). Evidence from a genome-wide association study (GWAS) in
humans has shown an association of IRF8 variants to chronic inﬂammatory conditions,
such as multiple sclerosis, cerebral malaria, and peripheral nerve injury (12). Xu et al.
reported that NOTCH-RBP-J signaling regulates the transcription factor Irf8 to promote
inﬂammatory macrophage polarization (13). A recent study suggested that IRF8 can stimulate interleukin-12 (IL-12) p40 and IL-23 production but inhibits IL-27 (14). Inhibition of
IL-27, in turn, increases the intra-CNS ampliﬁcation of Th1 and Th17 cells, leading to
microglial activation and accelerates neuroinﬂammation. Together, these studies infer the
crucial role of IRF8 in microglial differentiation, activation, and neuroinﬂammation.
Our previous study reported increased IRF8 expression in JEV-infected human
microglial cells (15). IRF8 plays a vital role in the physiology of both peripheral and
microglial cells; yet, its role in immune modulation in the context of JEV infection
remains unknown. Here, we conducted a study to understand the effect of IRF8 on
microglial activation and JEV replication in the brain. We have used an experimental
model of murine encephalitis induced by infection with JEV to investigate the role of
IRF8 in pathological inﬂammation. This model used 3- to 4-week-old C57BL/6 mice
infected with JEV (P20778 JEV-S3 strain) through the intraperitoneal (i.p.) route. Clinical
signs such as piloerection, body stiffening, restricted movement, tremor, and hind limb
paralysis appeared between day 5 and day 8 postinfection (p.i.) in susceptible mice,
progressing to death within 24 to 48 h postonset of clinical signs. Using IRF8 knockout
November 2021 Volume 95 Issue 21 e00406-21
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RESULTS
JEV infection induces IRF8 expression in infected mouse brain and microglia.
To understand JEV infection’s effect on IRF8 expression, we infected 3- to 4-week-old
C57BL/6 mice with the JEV P20778 strain through the i.p. route. The JEV NS1 protein
was detected in the infected brain by immunoﬂuorescence and Western blotting assay.
JEV infection was evident in infected mice, as viral protein and RNA were detected in
the brain, indicating that the virus reached the brain (Fig. 1A and B). Further, the IRF8
level was signiﬁcantly enhanced in infected mouse brains (Fig. 1C and D). Upon JEV
infection through the i.p. route, viral RNA was detectable in the brain as early as day 2
(p.i.) (Fig. 1E), and viral RNA level increased as the symptoms developed at day 5 p.i.
We also observed that the Irf8 transcript was signiﬁcantly increased in a time-dependent manner (Fig. 1E) and correlated with virus RNA levels in the brain.
To nullify that virus-induced IRF8 upregulation is not a strain-speciﬁc effect, we veriﬁed IRF8 expression in BALB/c mice infected with JEV strain GP78. We observed
increased IRF8 expression along with viral RNA and protein in the infected brain, suggesting IRF8 upregulation is not a strain-speciﬁc phenomenon; instead, it is a universal
phenomenon (Fig. 1F and G).
Apart from neuronal cells, JEV also infects microglial cells. Therefore, it is essential
to understand which cells are contributing to IRF8 upregulation in the infected brain.
We infected mouse neuroblastoma (N2a) as well as microglia (BV2 and N9) cells. We
checked IRF8 expression in the mock and infected cells. We observed that IRF8 did not
express in neuronal cells but constitutively expressed in microglial cells (Fig. 1H).
IRF8 deﬁciency affects the expression of microglia/macrophage activation
genes and modulates cytokine production in the JEV-infected mouse brain. IRF8 is
involved in the proinﬂammatory M1 phenotype’s commitment to microglia and macrophages (4, 11, 13). During JEV infection, it is evident that microglia become activated in
the nervous system and play an essential role in neuronal pathologies. The transcription
factor, IRF8, acts as a critical regulator of reactive microglia and activates a gene expression program that transforms microglia into a reactive phenotype (4). JEV infection also
induces cytokine expression in infected microglial cells. To assess the effect of IRF8 on
M1 and M2 marker gene expression and subsequent proinﬂammatory cytokine production in the infected brain, we performed a quantitative reverse transcription-PCR (qRTPCR) array and cytokine bead assay of the RNA and protein, respectively, from mock/
infected wild-type (WT) and Irf82/2 mice in the brain. We observed that most of the M1
genes (Il6, Fcgr4, Fcgr2b, Il1b, Cd86, H2Aa, Hexb, and Ccl2) were downregulated, while
M2 genes (e.g., Eda, Myb, Mrc1, Sphk1, Il3, and Il4) were upregulated (Fig. 2A).
Additionally, we checked the Mannose receptor, Iba1, CD68 markers at the protein level.
Compared to WT JEV-infected mice, all of the markers showed signiﬁcant reductions in
Irf82/2 mice (Fig. 2B). We further validated additional inﬂammatory M1 markers, e.g.,
Ccl2, Ccr2, Cd68, Cd86, Ym1, Socs3, Il12b. Their levels were signiﬁcantly increased in WT
mice but attenuated in Irf82/2 mice, suggesting microglia and inﬁltered macrophages
are less responsive toward proinﬂammatory response in Irf82/2 mice. Conversely, Ym1
was highly downregulated, while no signiﬁcant changes in Arg1, an M2, or anti-inﬂammatory markers were observed in WT and Irf82/2 mice (Fig. 2C). JEV pathophysiology is
associated with inﬂammatory cytokine release (16), inﬂuencing the disease's course and
the outcome. Hence, we measured tumor necrosis factor alpha (TNF-a), IL-6, monocyte
chemoattractant protein 1 (MCP1), IL-4, IL-23, and IL-1 b at the protein level. We found a
signiﬁcant increase in the level of three cytokines (TNF-a, IL-6, and MCP1) and a decrease
in the IL-4 and IL-1b levels in the WT and Irf82/2 infected brain compared to mockinfected mice (Fig. 2D). IL-27 is a member of the IL-6/IL-12 family and a pleiotropic cytokine playing an essential role in immunomodulation, as it suppresses inﬂammation by inhibiting Th17 response (14, 17) and promotes IL-10 production (18). We observed
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FIG 1 Interferon regulatory factor 8 (IRF8) expression increases upon JEV infection in mouse brains. Three-weeks-old (C57BL/6) mice (n = 3 mice/
group) were administered with JEV, p20778 strain (107pfu), or minimal Eagle’s medium (mock) through the intraperitoneal route. Brains were

(Continued on next page)
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increased IL-27 and IL-10 levels in infected Irf82/2 mice compared to those of WT
infected mice. Interestingly, we observed highly suppressed transforming growth factor
b (TGF- b ) and IFN-g in infected Irf82/2 mice compared to those in WT mice (Fig. 2D).
These results suggest that the presence of IRF8 is essential for the expression of microglia/macrophage activation genes and modulates JEV-induced proinﬂammatory cytokine
production in the infected brain.
IRF8 affects interferon genes and attenuates interferon-stimulated gene
expression in JEV-infected mouse brain. IRF8 acts as a positive regulator of IFN and
proinﬂammatory signaling in the murine system. Cooperative interaction of IRF8 and
other interferon regulatory factors (IRFs), e.g., IRF3, IRF7, IRF5, and IRF4, can modulate
type I and type II interferon-producing myeloid lineage cells (19, 20). Sufﬁcient production of interferons and antiviral genes is crucial for mounting an effective immune
response against invading pathogens. To understand how IRF8 modulation affects
interferon gene expressions and antiviral genes, we performed high-throughput RNA
sequencing (RNA-Seq) on whole-brain samples isolated from mock- or JEV-infected WT
and Irf82/2 mice. The Venn diagram showed the common and unique genes detected
in WT and Irf82/2 infected mice (Fig. 3A). We observed 17 dysregulated interferon
genes shared in the WT and Irf82/2 infected mouse brains. However, their expression
levels varied (Fig. 3B). Importantly, Ifng was detected only in WT infected mice but not
in Irf82/2 mice. When we looked at different IRFs, we found that Irf7, Irf8, Irf5, and Irf4
were signiﬁcantly upregulated in WT mouse brains upon infection with JEV. However,
these IRFs were reduced in Irf82/2 mice (Fig. 3C).
IRFs drive downstream interferon gene expressions via activation of the signal
transducer and activator of transcriptions (STATs). Therefore, we looked into various
STATs in WT and Irf82/2 infected mice. We observed a signiﬁcant reduction of phospho
STAT1, 2, and 3 in Irf82/2 mice compared to those in WT infected mice (Fig. 3D). We
further checked different interferon-stimulated genes expressions. The Ifna, Ifn b , and
Ifng levels were signiﬁcantly reduced in Irf82/2 mice upon JEV infection. Not only that,
except for Gbp5, all of the other Isgs (e.g., Iﬁt1, Iﬁt2, Gbp2, Isg15, Tgtp1) levels also
decreased signiﬁcantly in Irf82/2 mice (Fig. 3E). These results suggest that the absence
of IRF8 limits antiviral response against JEV infection in mice.
Interferon-gamma knockout mice exhibited a reduced level of IRF8 and
increased viral load in the infected brain. From our RNA-Seq data analysis, it is evident that IFN-g appeared to be associated with IRF8 expression and was severely compromised in Irf82/2 mice. To understand that IRF8-mediated effects were possibly associated with IFN-g expression, we infected Ifng2/2 mice with JEV and monitored them.
Interestingly, when we checked the IRF8 expression in the infected Ifng2/2 mice, we
observed a signiﬁcant reduction in the Irf8 in knockout mice compared to that in WT
mice at the transcript level (Fig. 4A). Moreover, JEV replication was signiﬁcantly
enhanced in Ifng2/2 mice (Fig. 4B to D). Interestingly, survival curve analysis suggested
that Ifng2/2 mice developed symptoms earlier than WT mice upon viral infection, but
no signiﬁcant changes were observed in survival time (Fig. 4F). Like Irf82/2 mice, Ifng2/2
mice exhibited lower expression of Ccl2, Cd68, Cd86, and Ym1, highlighting reduced
activation of microglia and inﬁltrating macrophages in the brain (Fig. 4E).
FIG 1 Legend (Continued)
harvested 24 h postonset of encephalitic symptoms. The viral and IRF8 proteins and RNA were detected by immunoﬂuorescence, Western blotting,
and qRT-PCR method. (A) Brain sections were stained for NS1 (red) and 49,6-diamidino-2-phenylindole (DAPI) (blue). (B, C) Relative JEV RNA level and
Irf8 transcript level were quantiﬁed by qRT-PCR (normalized to Gapdh mRNA; ****, P , 0.0001). (D) Total protein from brain homogenate was
Western blotted for NS1, IRF8, and GAPDH detection. (E) Viral RNA and IRF8 transcript expressions were measured at six different time points (0, 2, 3,
4, 5, 6 days postinfection [dpi]) in the brains of mock and infected mice (normalized to Gapdh mRNA; ****, P , 0.0001). BALB/c mice (p-10, n = 3
mice/group) were infected either with JEV, GP78 strain (105 PFU), or with 1 PBS (mock), and 24 h postonset of encephalitic signs, brains were
harvested to prepare RNA and protein. (F) Relative JEV RNA level and Irf8 transcript expression in the mock- and JEV-infected mice analyzed
by quantitative RT-PCR normalized to Gapdh mRNA). **, P , 0.01; ****, P , 0.0001. (G) Total protein from brain homogenate was Western blotted
for NS1, IRF8, and GAPDH detection. (H) Mouse neuronal cells (N2a) and microglia cell lines (BV2 and N9) were mock or JEV infected at an MOI of 5
and harvested 24 hours postinfection (h p.i.). Cell lysates were immunoblotted for IRF8 and GAPDH expression. All qRT-PCR data are represented as
mean 6 SD.
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FIG 2 Effect of Irf8 deﬁciency on microglia and inﬁltrating macrophage phenotype. Total RNA was isolated from the WT and Irf82/2 mouse brains of either
mock- or JEV-infected groups at 24 h postonset of symptoms to evaluate the gene expression. (A) The heat map represents different microglia marker
expression levels between WT and Irf82/2 infected mice obtained from the qPCR array. (B) Representative Western blotting data show the status of
different activation markers for microglia and inﬁltrated macrophages. (C) qRT-PCR was performed for quantitation of relative levels of indicated genes.
Gapdh mRNA level was used for normalization. All qRT-PCR data are represented as mean 6 SD. *, P , 0.05; **, P , 0.01; ***, P , 0.001; ****, P , 0.0001.
(D) Cytokine expression was quantiﬁed in the protein lysates of WT and Irf82/2 mouse brains of either mock- or JEV-infected groups using cytokine bead
array kits analyzed by FCAP and Qognit software. Representative data are shown; ****, P , 0.0001.
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FIG 3 Transcriptome proﬁling to elucidate genes signiﬁcantly affected in WT and Irf82/2 mouse brains following JEV infection analyzed by RNA-Seq. To
reveal the global transcriptional changes in the whole brain, RNA sequencing of RNA samples isolated from WT and Irf82/2 mouse brains of either mockor JEV-infected groups was performed. (A) Venn diagram showing differentially expressed genes generated by a comparative analysis of WT JEV versus WT,
Irf82/2 JEV versus Irf8 2/2, and Irf82/2 versus WT groups. (B) Venn diagram and heat map plot of genes associated with the interferon signaling pathway
identiﬁed using Metascape pathway enrichment analysis of infected versus uninfected WT and Irf82/2 transcript proﬁles. Blue represented higher
expression values. (C) Clustered heat map analysis of interferon regulatory factors extracted from infected versus uninfected WT and Irf82/2 transcript
proﬁles. (D) Representative Western blotting data showing the status of different STATs. (E) mRNA expression of interferon-stimulated genes identiﬁed
during RNA sequencing analysis was validated in the mock/infected WT and Irf82/2 mouse brains, analyzed by quantitative RT-PCR (normalized to Gapdh
mRNA). All qRT-PCR data are represented as mean 6 SD; *, P , 0.05; **, P , 0.01; ***, P , 0.001; ****, P , 0.0001.
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FIG 4 Effect of Ifng deﬁciency on viral load and activation genes of microglia and inﬁltrated macrophage.
Total RNA was isolated from the WT and Ifng2/2 mouse brains of mock- or JEV-infected groups at 24 h
postonset of clinical signs. (A, B) The relative RNA level of Irf8 and JEV transcripts were quantiﬁed by qRTPCR in WT (C57BL/6) and Ifng2/2 mouse brain RNA (normalized to Gapdh mRNA). ***, P , 0.001; **, P , 0.01.
(C) Virus titers in the brain homogenates of infected WT and Ifng2/2 mouse brains were determined through
plaque assay on the PS cell line. Virus titer is expressed as the number of virion particles per gram; **,
P , 0.01. (D) Total protein in the indicated groups was Western blotted for E protein, NS1, and GAPDH
detection. (E) qRT-PCR was performed for quantitation of relative levels of indicated genes (normalized to
Gapdh mRNA). Representative data are shown. All qRT-PCR data are represented as mean 6 SD; *, P , 0.05;
**, P , 0.01; ***, P , 0.001. (F) A survival study was performed to assess the survival of Ifng2/2 mice to JEV
infection. WT (C57BL/6) and Ifng2/2 mice (n = 12 in each group) were mock and JEV (107 PFU) infected,
followed by the appearance of encephalitic symptoms until death; ****, P , 0.0001. The data shown are the
combined results of three experiments.

Lack of Ifnc and Irf8 modulate immune cell abundance in circulation and affect
immune cell inﬁltration in JEV-infected brain. To check whether the lack of Ifng and
Irf8 had any impact on the activation of microglia or inﬁltrating immune cells in the
infected brain, we harvested mouse brains from WT, Ifng2/2, and Irf82/2 infected mice
November 2021 Volume 95 Issue 21 e00406-21
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24 h postonset of clinical signs and analyzed the inﬂux of immune cells in the brain.
Our ﬂuorescence-activated cell sorter (FACS) data (Fig. 5) show that activated macrophage (CD11b1 CD45hi) and microglia (CD11b1 CD45lo) cells were signiﬁcantly higher
in the WT than in the Ifng2/2 and Irf82/2 infected mice. Moreover, CD68 and CD86
marker (representing M1 microglia/macrophage activation) expressions were signiﬁcantly reduced in Ifng2/2 and Irf82/2 infected mice. Interestingly, we did not observe
signiﬁcant differences in NK1.1 levels in brains of WT, Ifng2/2, or Irf82/2 infected mice,
but the NKT cell count was higher in WT mice.
Compared to WT mice, CD4 and CD8 T cells were less abundant in Irf82/2 infected
brains and almost undetectable in Ifng2/2 infected mice. We did not observe signiﬁcant
changes in Ly6G1 cells in WT and Ifng2/2 infected mice, but 4- to 5-fold more inﬁltration of Ly6G1 cells was observed in Irf82/2 infected brains. Simultaneously, CD11b1
Ly6C1 cells representing the monocytes were highly abundant in WT mice compared
to those in Ifng2/2 and Irf82/2 infected mice. Interestingly, we did not see much difference in CD11b1 CD451, Ly6C1, and CD41 populations in peripheral blood between
WT and Ifng2/2 mice (Fig. 6). However, we did notice an increased accumulation of
CD11b2 Ly6C1, representing myeloid progenitor cells in the blood of Ifng2/2 infected
mice (Fig. 6) but failing to migrate to the brain (Fig. 5). In contrast, Irf82/2 mice exhibited a higher abundance of CD11b1 CD451, Ly6G1, and Ly6C1 cells in the blood. Apart
from this, CD4 and CD8 cells were less abundant in Irf82/2 infected mice (Fig. 6).
Thus, our data suggest that the lack of IFN-g reduced IRF8 expression, and the absence of Irf8 or Ifng modulates the abundance of immune cells in the blood and brain.
Moreover, lack of Ifng and IRF8 probably affects immune cell inﬁltration and activation
in response to JEV infection.
Since Irf82/2 infected mice showed a lower Ifng level in the brain, we further
checked the percentage of the Ifng-positive population in brain-inﬁltrating cells. The
NK1.11 and CD31 cells are the primary immune cells that showed Ifng1 staining in WT
and Irf82/2 infected mice. Although NK1.11 cells were abundant in WT and Irf82/2
infected mice, a very low percentage of NK1.11 cells were positive for Ifng in Irf82/2
infected mice (Fig. 7). It has been reported previously that IRF8 deﬁciency increases the
frequency of immature NK cells and decreases mature NK cells (21). Therefore, the
reduced number of Ifng1 NK1.1 inﬁltrating cells is probably a reﬂection of more immature NK cells in the Irf82/2 infected mouse brain. Irf8 also affects CD31 T cell development (22). A lower Ifng level may be due to fewer CD31 cells abundant in Irf82/2
infected mice (Fig. 5 and 6). Thus, reduced Ifng level in the Irf82/2 JEV-infected brain is
probably due to a defect in the immune cell developmental process and lower abundance of T cells in infected mice.
JEV replication augmented in Irf82/2 mice. To assess the contribution of IRF8 to
pathological inﬂammation, we infected Irf82/2 mice with the JEV P20778 strain. Virus
replication in the brain, the appearance of neurological symptoms, and overall mouse
survival were recorded over 15 days. While all C57BL/6 WT mice developed symptoms
and succumbed by day 8 p.i., Irf82/2 mice developed severe symptoms early, but no
signiﬁcant differences were found in the survival time (Fig. 8A). All of the Irf82/2 mice
were deﬁcient in IRF8 at the transcriptional level (Fig. 8B). We checked JEV viral load
and NS1 protein expression in WT and Irf82/2 infected mice to conﬁrm that the mice
died due to viral infection. We observed a signiﬁcantly higher intracellular viral load
and a higher NS1 protein expression level in Irf82/2 infected mice than in WT infected
mice (Fig. 8C to E).
Functional IRF8 expression in IRF8 KO cell line augments IFN-cand reduced JEV
replication. Since IRF8 is expressed in myeloid lineage cells, we checked JEV infection
in IRF8 knockout HAP-1 cells. JEV infects HAP-1 cells, as NS1 expression was observed
in HAP-1 cells at 24 h p.i. IRF8 expression increased in JEV-infected HAP-1 cells compared to that in HAP-1 uninfected cells (Fig. 9A). To understand the effect of IRF8 on viral replication, we used IRF8 knockout HAP1 cells. These cells had a 5-bp deletion
(Irf85bp del) at the initiation site, leading to the generation of a truncated nonfunctional
IRF8. The IRF8 at the transcript level is undetectable in Irf85bp del cells. High viral load
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FIG 5 Immune cells inﬁltration into the brain 24 h postonset of clinical signs in WT, Ifng2/2, and Irf82/2 mice. Myeloid and lymphoid cells were enriched
from the brains of WT (n = 3), Ifng2/2 (n = 3), and Irf82/2 (n = 5) mice either of mock- or JEV-infected groups, by Percoll gradient for the ﬂow cytometric
analysis. Representative dot plots (left) show percentage of cells in each quadrant; positive for the indicated markers on the axis and bar graph (right
panel) indicates the quantiﬁcation of CD451, CD11b1, CD681, CD861, Ly6C1, Ly6G1, CD31, CD41, CD81, and NK1.11 expression on leukocytes (**,
P , 0.01; ***, P , 0.001; ****, P , 0.0001). Each dot represents cells from an individual mouse. Error bars are represented as mean 6 SD.
November 2021 Volume 95 Issue 21 e00406-21

jvi.asm.org

10

Downloaded from https://journals.asm.org/journal/jvi on 08 November 2021 by 2601:4a:c003:a5e0:312a:d46b:f6fd:47c3.

Tripathi et al.

Journal of Virology

FIG 6 Immune cell abundance in blood 24 h postonset of clinical signs in WT, Ifng2/2, and Irf82/2 mice. Leukocytes from the blood of WT (n = 3), Ifng2/2
(n = 3), and Irf82/2 (n = 5) mice, either of mock- or JEV-infected groups, were subjected to ﬂow cytometric analysis. Representative dot plot (left) shows the
percentage of cells in each quadrant, positive for the indicated markers on the axis. Bar graph (right) indicates the quantiﬁcation of CD451, CD11b1,
Ly6C1, Ly6G1, CD31, CD41, CD81, and NK1.11 expression on leukocytes (**, P , 0.01; ***, P , 0.001; ****, P , 0.0001). Each dot in the bar graph
represents cells from an individual mouse. Error bar are represented as mean 6 SD.
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was also observed at RNA and protein levels in Irf85bp del HAP-1 cells compared to those
in the WT (Fig. 9B to D), indicating that the absence of IRF8 signiﬁcantly augments JEV
replication peripheral cells.
To understand if IRF8 works as a restriction factor for JEV replication, we overexpressed functional IRF8 in HAP-1 Irf85bp del cells by transfecting the retrovirus vector
containing functional mouse IRF8. After developing the stable cell line, we checked
IRF8 and viral protein expression by Western blotting (Fig. 9E). JEV-NS1 protein level
signiﬁcantly decreased in HAP1 Irf85bp del cells overexpressing mouse IRF8 protein
(Fig. 9E). Further, we checked the IFN-g level and found it increased upon JEV infection in cells and supernatant where functional IRF8 was present (Fig. 9F). Thus, our
results point toward the association of IRF8 and IFN-g, which together may affect viral
replication.
DISCUSSION
IRF8 plays a signiﬁcant role in microglial activation and is also involved in mounting
an antiviral response against invading pathogens. Microglial cells are susceptible to
JEV infection, and prolonged microglial activation in the proinﬂammatory stage leads
to severe inﬂammation in the brain, causing permanent neuronal damage. In this
study, we have explored the possible role of IRF8 in the context of JEV replication and
inﬂammation. Using the Irf82/2 mice, we demonstrated (i) the effect of IRF8 modulation on JEV replication in the brain, (ii) that the absence of the Irf8 function in Irf82/2
mice did not protect against JEV infection, (iii) that susceptibility to viral infection is
also associated with the level of Ifng; and (iv) that the lack of Ifng or Irf8 alters immune
cell abundance in circulation and in the infected brain.
Viral infection in mice induces IRF8 expression in infected brains. Interestingly, the
absence of functional IRF8 augmented viral replication in the infected mouse brain.
Conversely, overexpression of functional IRF8 in the Irf8-defective cells (Irf85bp del) attenuated viral replication. The increased viral replication may be because of reduced IFNmediated antiviral response and was impaired in the Irf82/2 mice more than in WT
mice. This is consistent with previous reports (21, 23, 24) where increased susceptibility
to infections was reported in Irf82/2 mice. The absence of an adequate antiviral
response may allow the virus to multiply.
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FIG 7 Intracellular staining of Ifng in inﬁltrating NK1.11 and CD31 cells in infected brains. Lymphocytes
were enriched from the brains of WT (n = 3) and Irf82/2 (n = 3) mice from either the mock- or JEV-infected
group by Percoll gradient for ﬂow cytometric analysis. Representative dot plot (left) shows the percentage of
cells in each quadrant, positive for the indicated markers on the axis. Bar graph (right) indicates the
quantiﬁcation of NK1.11, NK1.11 IFN-g1, CD31, and CD31 IFN-g1 expression on lymphocytes (**, P , 0.01; ***,
P , 0.001; ****, P , 0.0001). Each dot in the bar graph represents cells from an individual mouse. Error bar
represents mean 6 SD.
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FIG 8 Effect of loss of IRF8 on JEV replication. (A) A survival study was performed to assess the survival of
Irf82/2 mice to JEV infection. WT (C57BL/6) and Irf82/2 mice (n = 18 in each group) were mock or JEV (107 PFU)
infected and followed from the appearance of encephalitic signs until death; ****, P , 0.0001. Data shown are
the combined results of three experiments. (B) The relative RNA level of Irf8 transcripts was quantiﬁed by qRTPCR in WT (C57BL/6) and Irf82/2 mice of mock- and JEV-infected RNA samples (normalized to Gapdh mRNA). (C,
D) The relative level of viral and virus titer in the brain homogenates of infected WT and Irf82/2 mouse brains
was determined through qRT-PCR and plaque assay. Virus titer is expressed as the number of virion particles
per gram; **, P , 0.01. (D, C) ***, P , 0.001; ****, P , 0.0001. (E) The total protein of indicated groups was
Western blotted for NS1 and GAPDH detection.

Considering the high viral load in the brain, we expected Irf82/2 mice to die before
the WT mice. However, we did not observe signiﬁcant changes in survival time. It is important to note that JEV pathogenesis depends on viral load and the inﬂammation
induced in the brain. In WT mice, an adequate antiviral response can probably restrict
virus replication to some extent in the brain. As the virus enters the brain, prolonged
microglial activation and increased inﬁltration of activated immune cells may cause
severe neuronal damage, leading to fatal outcomes. Surprisingly, despite reduced
microglia/macrophage proinﬂammation markers in the Irf82/2 mouse brain, the absence of IRF8 did not prevent the development of neurological signs nor its prolonged
survival upon infection.
This is consistent with the previous report where Irf82/2 mice showed increased
lethality following intranasal challenge with low-dose West Nile virus (WNV) compared
with similarly infected WT mice (23).
It is important to note that although a high abundance of CD11b1 CD451 cell populations were detected in the blood of Irf82/2 infected mice, less inﬁltration of these
cells was observed in the infected brain (Fig. 5 and 6). This could be the reﬂection of
reduced trafﬁcking ability. Several studies demonstrated earlier that the expression of
chemokines, such as Ccl2, Ccl3, Ccl4, Ccl5, and Cxcl10, during viral infection is associated
with enhanced trafﬁcking of leukocytes into the brain (25). Compared to WT mice,
Irf82/2 mice exhibited a lower level of these chemokines in response to JEV infection
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FIG 9 Effect of IRF8 overexpression in myeloid cell lines. (A) Haploid1 (HAP1) cell line was mock or JEV infected at an MOI of 5 for 24
h. Expression of IRF8 and viral envelope protein were detected by the immunoﬂuorescence method. The relative level of human Irf8
transcript was quantiﬁed by qRT-PCR in a HAP1 cell that was mock or JEV infected at an MOI of 5 for 24 h (right). (B, C) The relative
level of Irf8 and viral RNA were determined by qRT-PCR (**, P , 0.01). (D) Viral protein (NS1) was immunoblotted in the lysates of the
mock and infected HAP1 and HAP1 Irf85bp del cells. GAPDH was used as an internal control. (E) HAP1 Irf85 bp del cells transduced with
pMig-CD8t control or pMig-IRF8-cd8t plasmid were mock or JEV infected at an MOI of 5 for 24 h. Cell lysate was prepared from
mock- and JEV-infected HAP1 Irf85 bp del transduced with pMig-CD8t control or pMig-IRF8-cd8t plasmid, and Western blotting was
performed to determine JEV and mouse IRF8 level in overexpressed cells. All qRT-PCR data are represented as mean 6 SD and were
normalized to Gapdh. (F) hIFN-g expression was quantiﬁed in the protein lysates (left) and supernatant (right) of mock- and JEVinfected HAP1 Irf85 bp del transduced with pMig-CD8t control or pMig-IRF8-cd8t plasmid groups using cytokine bead array kits analyzed
by FCAP software. Representative data is shown; **, P , 0.01; ***, P , 0.001; ****, P , 0.0001.
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(data not shown). Like West Nile virus disease (26), low expression of the chemokine receptor Ccr2 expression in Irf82/2 and Ifng2/2 mice in response to JEV infection probably
indicates the reduced migration ability to inﬁltrate leukocytes in the inﬂamed brain.
Our data are further supported, as shown in Fig. 2A, where reduced activation markers
and cytokine expression were observed in response to viral infection in Irf82/2 mice.
It is important to note that although the Ifng level signiﬁcantly goes down in Irf82/2
mice, TNF-a, IL-6, and MCP1 levels did not change and were comparable with those of
WT mice. These data suggest that TNF-a, IL-6, and MCP1 are probably independent of
IRF8 expression. It was reported earlier that the IRF8 expression was markedly upregulated in microglia but not in neurons or astrocytes (4). The neurons and astrocytes
have been associated with producing inﬂammatory mediators in several neuroinﬂammatory scenarios, including viral infection in the brain (27). In the absence of microglial
activation, astrocytes and neuronal cells may contribute to the production of TNF-a, IL6, and MCP1 (16, 28–31). Another source of these cytokines could be the inﬁltrating
neutrophils. The deﬁciency of IRF8 enhances neutrophil biogenesis (32). As a result, we
observed a signiﬁcant number of Ly6G1 cells inﬁltrated in the brain. It was reported
earlier that these cytokines impart a detrimental effect on the pathology of JEV (16,
33). Therefore, the death of Irf82/2 mice may be due to a high abundance of proinﬂammatory cytokines, especially TNF-a, IL-6, and MCP1 in JEV-infected mouse brains.
We also observed that susceptibility to viral infection is associated with impaired
production of Ifng. The Ifng production in response to viral infection reduced 3- to 4fold in Irf82/2 mice. Similar to our study, Holtschke et al. reported an enhanced susceptibility to viral infections associated with impaired production of IFN-g in Irf82/2 mice
(34). Induction of IFN-g appears to be critical for restricting JEV replication (35). It is important to note that Ifng2/2 mice also exhibited a reduced level of Irf8 and an increased
viral load level in the mouse brain as observed in Irf82/2 mice. This is further supported
by our in vitro complementation study (Fig. 9E and F), where the introduction of functional IRF8 into IRF8 KO cells enhanced IFN-g expression concomitant reduction in viral
replication. It was reported earlier that IFN-g is critical in recovery from primary infection with JEV by a mechanism involving suppression of virus growth in the CNS and
that T cells are the primary source of the cytokine that promotes JEV clearance from
the brain (35). Moreover, the NK cell population is dispensable for control of JEV infection in the periphery and the CNS (35).
To examine whether reduced Ifng is associated with the abundance or defect in the
function of immune cells, we checked immune cells in the blood and brain of Irf82/2
mice. As reported earlier, the transcription factor IRF8 is required for the development
and maturation of myeloid cells (dendritic cells, monocytes, macrophages) (36, 37). We
observed that the abundance of inﬁltrating immune cells in the infected brain directly
reﬂects the cell population detected in circulation. Our FACS data from Irf82/2 mice
showed reduced CD31 T cells in the blood and the brain. Moreover, as shown in Fig. 7,
for IRF82/2 mice, reduced levels of Ifng1 cells are consistent with the reduced level of
CD31 T cells.
However, from our study, it is not clear how IRF8 regulates the expression of the
IFN-g gene. The regulatory regions of the IFN-g do not have ISRE or a similar element.
Therefore, the direct effect of IRF8 on gene transcription is unlikely. Similar to our
study, Holtschke et al. (34) also reported that an association of IRF8 and IFN-g expression is more likely indirect. It could reﬂect the inﬂuences of IRF8 on other elements of
the cytokine network, which may be perturbed in Irf82/2 mice (34).
However, Irf82/2 or Ifng2/2 mice exhibited reduced levels of activated microglia and
inﬁltrated macrophage in brains, as most of the markers showed low expression in the
brain (Fig. 2 and 5). The reduced expression level is possible because Irf8 is a critical
transcription factor for maintaining microglia's physiological phenotype.
In conclusion, our study suggested that IRF8 modulation affects viral replication in
the mouse brain. The absence of IRF8 alters immune cell abundance in the blood and
brain of infected mice, reduces the IFN-g level, and increases the viral load in the brain
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leading to death. Overall, our study provides evidence for the critical involvement of
Irf8 in immune cell abundance and antiviral response in the mice following JEV
infection.

Ethics statement. The Animal Ethics Committee of the Translational Health Science and Technology
Institute (THSTI) (approval number IAEC/THSTI/2017-8) and National Institute of Immunology (NII) (approval number IAEC/NII/494/18) approved all animal procedures that were used in the study. C57BL/6
WT, Ifng2/2, and Irf82/2 mice (3 to 4 weeks old) were maintained at the Small Animal Facility of the
National Institute of Immunology, New Delhi. JEV-infected mice have been housed in HEPA ﬁlter-top
cages under class II biohazard conditions, with food and water provided ad libitum. Virus propagation in
pups and characterization was done at the Small Animal Facility available at the THSTI campus.
Virus propagation. We used JEV strain P20778 (JEV-S3) in all of the experiments. The virus (104 PFU/
10 m l) was inoculated in the cerebrum of 3-day-old suckling mice for propagation. The pups and mothers were housed and maintained at the Small Animal Facility within the NCR Biotech Science cluster
campus. On day 3 p.i., brains were harvested from pups to prepare 40% (wt/vol) suspension by homogenizing the brain in minimal Eagle medium (MEM) (Invitrogen, Carlsbad, CA, USA). The homogenate was
centrifuged to remove debris, and the supernatant containing the virus was aliquoted and stored at
280°C.
Cell culture and viral infection. The mouse microglia cell lines (BV2 and N9) (kindly provided by
Anirban Basu, National Brain Research Centre, Manesar, India) were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA, USA) and RPMI 1640 (HyClone; GE Healthcare Life
Sciences, UT), respectively. Mouse neuronal cell line (N2a) was procured from the National Centre for
Cell Sciences, Pune, India, propagated in Dulbecco’s modiﬁed Eagle’s medium (Invitrogen, Carlsbad, CA,
USA). The human myeloid (HAP1 and HAP1 Irf85bp del cell lines) cell lines (purchased from Horizon
Discovery, Cambridge, UK; HZGHC004199c005) were maintained in Iscove’s modiﬁed Dulbecco medium
(IMDM) (HyClone; GE Healthcare Life Sciences, UT). All media were supplemented with 10% fetal bovine
serum (FBS) (Gibco, USA), 2 mM L-glutamine, and 100 m g/ml penicillin-streptomycin-glutamine (PSG)
(Invitrogen, Carlsbad, CA, USA). Cell lines were maintained at 37°C in the CO2 incubator. Cells were
seeded at 60% conﬂuence and infected with JEV at a multiplicity of infection (MOI) of 5 for 1 h, following
infection medium supplemented with FBS, and PSG was added. Cells were harvested at 24 h p.i. for
lysate preparation in radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich, Saint Louis, MO,
USA). TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was added to cells for RNA extraction as per the
manufacturer protocol.
Mice and infection. Mice (WT, Irf82/2, and Ifng2/2) were obtained from The Jackson Laboratory,
USA; C57BL/6 WT, Ifng2/2, and Irf82/2 mice (3-4 weeks old) were maintained and infected at the Small
Animal Facility of the National Institute of Immunology (NII), New Delhi. Mice of either sex were randomly divided into two groups. Mice in the infection group were inoculated through the intraperitoneal
(i.p.) route with 1  107 PFU/100 m l of JEV. In contrast, mice in the mock-infected group received an
equal volume of sterile Eagle’s minimal essential medium (MEM) (Invitrogen, Carlsbad, CA, USA) by the
same route. Mice were weighed and observed until they developed clinical symptoms of viral encephalitis. The time before the i.p. infection is referred to as day 0. For survival study, mice were followed until
death. While preparing RNA or protein samples, mice were sacriﬁced 24 h after the onset of symptoms,
followed by transcardial perfusion with ice-cold 1 phosphate-buffered saline (PBS). Brains were harvested and stored at 280°C until further use.
Virus titration by plaque-forming assay. Baby hamster kidney (BHK) cells obtained from the
National Centre for Cell Science, Pune, India, were maintained at 37°C with 5% CO2 in minimal Eagle’s
medium with 10% FBS, 1% penicillin-streptomycin, and glutamine. BHK cells with 60% conﬂuence per
well were used for titrating the virus. Cells were washed with 1 PBS followed by the addition of 10-fold
serially diluted virus stock prepared in serum-free Eagle’s minimal essential medium for 1 h, incubated
at 37°C with gentle rocking. Post incubation, cells were washed with 1 PBS and overlaid with 2 ml of
agarose type VII (Sigma) in MEM, prepared by mixing a 1:1 ratio of 2 minimal Eagle’s medium
(HiMedia) with 10% FBS and a 2% solution of low melting agarose. After 3 days, cells were ﬁxed with
3.7% formaldehyde (Sigma). The overlay plugs were removed, and cells were stained with 1% crystal violet (Sigma) for 5 min. Plaques were counted, and the virus titer was calculated using the following formula: virus titer (PFU/ml) = average PFU/volume of infection (ml)  dilution factor.
RNA extraction and qRT-PCR. Total RNA was extracted from the brain using the RNeasy minikit
(Qiagen, Hilden, Germany) following the manufacturer’s protocols. cDNA was prepared in two steps
using the GoScript reverse transcription system (Promega, Madison, WI, USA). RNA extracted from samples was analyzed in triplicate by the real-time ﬂuorescence detection method with SYBR green DNA
binding ﬂuorescent dye (SYBR Premix Ex Taq; TaKaRa, Otsu, Shiga, Japan) on a QuantStudio 6 ﬂex realtime PCR (Applied Biosystems, Foster City, CA, USA) detection system. Relative expression was calculated
using the threshold cycle (CT) method with uninfected as the reference, and Gapdh (glyceraldehyde-3phosphate dehydrogenase) was used as an internal control. Microglial marker expression was quantiﬁed
following the manufacturer's protocol for GeneQuery mouse microglial polarization markers quantitative
PCR (qPCR) array kit (MGK114, Science cell, Carlsbad, CA, USA).
Immunoblotting. Mouse brains were minced and homogenized in Tris-HCl buffer (pH 7.5) with
1 mM phenylmethylsulfonyl ﬂuoride (PMSF) (Sigma-Aldrich, Saint Louis, MO, USA). Samples were centrifuged at 13,000 rpm at 4°C for 15 min to obtain clear lysate that was aliquoted and stored at 280°C.
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According to the manufacturer's speciﬁcation, protein concentration was quantiﬁed following bicinchoninic acid (BCA) assay (Pierce, Rockford, IL, USA). For Western blotting, an equal concentration of protein
(30 m g) was resolved with 10% SDS-PAGE and transferred onto a nitrocellulose membrane. After blocking with 5% (wt/vol) skimmed milk, the membrane was probed with rabbit GAPDH antibody (at dilution
1:10,000, GTX100118; GeneTex, Irvine, CA, USA), in-house rabbit polyclonal antibody to JEV NS1 protein
(at dilution 1:10,000), mouse JE1 antibody (at dilution 1:1,000, ab71671; Abcam, Cambridge, UK), rabbit
Mannose receptor (at dilution 1:1,000, ab64693; Abcam, Cambridge, UK), mouse CD68 (at dilution
1:1,000, ab955; Abcam, Cambridge, UK), mouse IBA1 (at dilution 1:1,000, MABN92; Merck Millipore,
Darmstadt, Germany), rabbit STAT1 (at dilution 1:1,000, sc346; Santa Cruz Biotechnology, Dallas, TX,
USA), rabbit Phospho-STAT1 (at dilution 1:1,000, Tyr701-58D6; Cell Signaling Technology, MA, USA), rabbit Phospho-STAT2 (at dilution 1:1,000, Y690-D3P2P; Cell Signaling Technology, MA, USA), rabbit STAT2
(at dilution 1:1,000, D9J7L; Cell Signaling Technology, MA, USA), mouse STAT3 (at dilution 1:1,000,
124H6; Cell Signaling Technology, MA, USA), rabbit Phospho-STAT3 (at dilution 1:1,000, 124H6; Cell
Signaling Technology, MA, USA), and mouse IRF8 antibody (at dilution 1:1,000, sc365042; Santa Cruz
Biotechnology, Dallas, TX, USA) to check their expression in infected and uninfected mouse brain lysate.
For chemiluminescence detection, a luminol reagent (Santa Cruz Biotechnology, Dallas, TX, USA) was
used, and the signal was visualized in the ChemiDoc XRS system (Bio-Rad, Hercules, CA, USA).
Densiometric analysis of the blot was done using ImageJ software to determine the signal intensity.
Cytokine bead array. Cytokine bead array (CBA) was performed to quantitatively measure the cytokine level of six cytokines (IL-6, TNF-a, IFN-g, MCP1, IL12p70, IL-10) using an assay kit procured from BD
Biosciences (San Diego, CA, USA). Four other cytokines (TGF- b , IL-27, IL-23, and IL-1 b ) were measured
using an assay kit procured from BioLegend (San Diego, CA, USA), and data were analyzed using CBA
software (FCAP 3.0.1 and Qognit). Twenty-ﬁve micrograms of protein lysate and 100 m l of cell supernatant were used for analysis. Data were acquired using CellQuest Pro software in the FACSCalibur cell analyzer (BD Biosciences, San Jose, CA, USA). The quantity of the cytokines detected in the lysate samples
was measured against the standard curve obtained from the deﬁned concentration of protein provided
with the assay kit.
Immunostaining. Mice were perfused with sterile cold 1 PBS as well as with 4% paraformaldehyde
(PFA). The brains were removed and kept in 4% paraformaldehyde for 24 h at 4°C followed by incubation in 30% sucrose solution until immersion. Brains were taken out and embedded in OCT (Tissue-Tek,
Saint Louis, MO, USA) and frozen at 220°C. Thirty-micrometer cryostat sections of the brain were made
with the help of cryostat (Microm HM550; Thermo scientiﬁc, Runcorn, UK) and mounted on slides. The
antigen retrieval process was performed at 70°C using antigen unmasking solution (Vector Laboratories,
Burlingame, CA, USA). After permeabilization and blocking, the slides were processed for the JEV NS1
antigen. Images were captured at 60 magniﬁcation using a confocal microscope, Olympus FV3000. For
in vitro immunostaining, HAP1 cell lines seeded at 60% conﬂuence were either mock and JEV infected
(MOI = 5) for 1 h, then inoculum was removed, and complete medium was added to the cells. Cells were
washed with 1 PBS and ﬁxed with 4% PFA (Sigma-Aldrich, Saint Louis, MO, USA). After permeabilization and blocking, cells were incubated with the IRF8 antibody (at dilution 1:500, ab28696; Abcam,
Cambridge, UK) as well as NS1 (1:1,000) for overnight incubation at 4°C. The ﬂuorochrome-conjugated
secondary antibodies (A11011, Alexa ﬂuor 568 goat anti-rabbit; A11029, Alexa ﬂuor 488 goat anti-mouse;
Invitrogen; 1:500) were used to detect the proteins. The slides were observed under a confocal microscope (Olympus FV3000) at 100 magniﬁcation. Images were captured and analyzed using software
FluoView (FV 31S-SW) and cellSens Dimension, respectively.
Immune cell isolation from mouse blood and brain for ﬂow cytometry analysis. Blood was collected from mice through retro-orbital bleeding and added to ACK lysis buffer (BioLegend, WaySan
Diego, CA) for red blood cell lysis as per manufacturer protocol. Mice were anesthetized with ketamine
and xylazine and perfused with ice-cold PBS. The brain was removed and homogenized with a Dounce
homogenizer in cold Hanks balanced salt solution (HBSS) buffer (Sigma-Aldrich, Saint Louis, MO, USA).
Brain homogenate was resuspended to prepare 30% isotonic Percoll (Sigma-Aldrich, Saint Louis, MO,
USA), which was overlayered on 70% isotonic Percoll. Then a gradient was centrifuged at 500  g for
25 min at 18°C. Mononuclear cells were collected from the 30%/70% interface and washed with PBS. To
identify microglia, monocytes, and granulocytes, isolated mononuclear cells from blood and brain were
ﬁrst preincubated with anti-mouse CD16/32 antibody TruStain FcX as per manufacturer protocol
(BioLegend, San Diego, CA) for 15 min at 4°C to block Fc receptors and then simultaneously stained with
ﬂuorochrome-conjugated antibodies (APC-CD11b, FITC-CD45 [at dilution 1:100; Miltenyi Biotec,
Gladbach, Germany], FITC-Ly6C [at dilution 1:50; Invitrogen, Vilnius, Lithuania], V450-Ly6G [at dilution
1:50; BioLegend, San Diego, CA, USA], BV421-IFN-g [at dilution 1:25; BioLegend, San Diego, CA, USA]). For
T cell immune proﬁling, all of the antibodies were procured from BioLegend (BV510 anti-mouse CD3«
[at dilution 1.5:50], PerCP/Cyanine5.5 anti-mouse CD4 [at dilution 1:50], Brilliant Violet 421 anti-mouse
CD8a [at dilution 1:50], and APC/Cyanine7 anti-mouse NK-1.1 [at dilution 1:25]). Cells were then rinsed
with FACS buffer and run on the BD FACS Verse (BD Biosciences, San Jose, CA). For intracellular staining,
cells were ﬁxed and permeabilized using BD Cytoﬁx/Cytoperm (BD Biosciences, San Jose, CA) as per the
manufacturer protocol. Data were analyzed using BD FACS Suite v1.0.6 (BD Biosciences, San Jose, CA)
and FlowJo v10 (FlowJo LLC).
Transduction of haploid cells. Packaging cells were transfected with retroviral vectors pMig-control-IRES-hCD8t and pMig-Irf8-IRES-hCD8t (38, 39), and supernatant containing virus was collected after 48 h. For retroviral transduction, HapI-Irf85bp del cells (1  106) were incubated with Mig-controlIRES-hCD8t and Mig-Irf8-IRES-hCD8t supernatants of retroviruses expressing the truncated human
CD8 surface marker by spinoculation (2,400 rpm, 33°C, 1 h) with 4 m g/ml Polybrene. One day
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